Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

e2v secures contract renewal

19 Dec 2008 07:00

RNS Number : 4476K
e2v technologies PLC
19 December 2008
 



19 December 2008 

e2v technologies plc

e2v secures contract renewal 

e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces it has won a contract renewal worth £4.1m.

The contract renewal is with Alphatron Electronic Parts, headquartered in Holland and with further worldwide facilities, and is for the supply of products from e2v's electron device and sub-systems (EDS) division to support Original Equipment Manufacturers (OEMs) and replacement requirements for commercial radar systems.

Delivery is scheduled over a 12 month period.

Keith Attwood, Chief Executive of e2v, commented: "The EDS business model is characterised by a large proportion of spares business, relative to OEM requirements for new systems. This contract renewal reflects the continued need and opportunity to support the large in-service field population of systems with high quality, replacement product. Further contract renewals for the radiotherapy market will be announced in the coming weeks, underpinning e2v's future performance."

For further information:

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Mike Hannant

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7269 7291

Jon Simmons

   

NOTES FOR EDITORS

e2v 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical and science, aerospace and defence, and commercial and industrial markets.

e2v has 4 major product groups:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, and radar systems

Advanced Imaging sensors and cameras for applications including industrial process control, dental X-ray systems, space science and life sciences

Specialist semiconductors, including logic, memory and microprocessors for high reliability mission-critical programs in avionics, defence and telecommunications, sensor data acquisition, and high speed data conversion

A range of professional sensing products for applications including fire, rescue and security thermal imaging, X-ray spectroscopy, and military surveillance, targeting and guidance

For the year ended 31 March 2008, e2v achieved sales of £205m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. 

The Company is headquartered in the United Kingdom and has approximately 1800 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available from www.e2v.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGUGQPPUPRPUR
Date   Source Headline
6th Apr 20105:10 pmRNSHolding(s) in Company
1st Apr 20107:00 amRNSUpdate on Restructuring
29th Mar 20103:10 pmRNSHolding(s) in Company
22nd Mar 20104:35 pmRNSPrice Monitoring Extension
19th Mar 20104:37 pmRNSPrice Monitoring Extension
11th Mar 20104:08 pmRNSTotal Voting Rights
8th Mar 20104:25 pmRNSDirector/PDMR Shareholding
5th Mar 20102:55 pmRNSDirector/PDMR Shareholding
1st Mar 20107:00 amRNSUpdate on Restructuring
17th Feb 201011:15 amRNSTotal Voting Rights
2nd Feb 20107:00 amRNSInterim Management Statement
22nd Jan 20102:15 pmRNSHolding(s) in Company
19th Jan 201010:01 amRNSTotal Voting Rights
18th Dec 20093:55 pmRNSHolding(s) in Company
16th Dec 20092:31 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
15th Dec 20094:25 pmRNSDirector/PDMR Shareholding
10th Dec 20094:27 pmRNSTotal Voting Rights
9th Dec 20095:33 pmRNSHolding(s) in Company
9th Dec 20095:32 pmRNSHolding(s) in Company
9th Dec 20095:29 pmRNSHolding(s) in Company
9th Dec 20095:25 pmRNSHolding(s) in Company
9th Dec 20095:25 pmRNSHolding(s) in Company
8th Dec 20095:32 pmRNSHolding(s) in Company
8th Dec 20095:26 pmRNSHolding(s) in Company
8th Dec 200910:03 amRNSResults of Rump Placing
8th Dec 20097:00 amRNSResults of Rights Issue
4th Dec 20092:26 pmBUSDisclosure of Short Position
2nd Dec 20093:23 pmRNSNotification of Transactions of Directors
2nd Dec 20091:58 pmBUSDisclosure of Short Position
27th Nov 200911:04 amRNSNotification of Transaction by Directors
25th Nov 20093:45 pmRNSNotification of Major Interests in Shares
25th Nov 20093:43 pmRNSNotification of Major Interests in Shares
25th Nov 20093:42 pmRNSNotification of Major Interests in Shares
25th Nov 20093:39 pmRNSNotification of Major Interests in Shares
25th Nov 20093:35 pmRNSNotification of Major Interests in Shares
20th Nov 20094:40 pmRNSSecond Price Monitoring Extn
20th Nov 20094:35 pmRNSPrice Monitoring Extension
20th Nov 200910:33 amRNSResults of General Meeting
10th Nov 20091:53 pmRNSTotal Voting Rights
6th Nov 20091:12 pmRNSProspectus Clarification
5th Nov 20094:20 pmRNSNotification of Major Interests in Shares
4th Nov 20094:41 pmRNSNotification of Major Interests in Shares
2nd Nov 20094:45 pmRNSPublication of Prospectus
2nd Nov 20093:39 pmRNSNotification of Major Interests in Shares
29th Oct 20094:40 pmRNSSecond Price Monitoring Extn
29th Oct 20094:35 pmRNSPrice Monitoring Extension
29th Oct 20097:10 amRNSInterim Results
29th Oct 20097:10 amRNSFirm Placing and Rights Issue
9th Oct 20097:00 amRNSPeriod End Update
7th Oct 200911:51 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.